Document is current
Any future updates will be listed below
-
Authors
Pace, Lydia E. https://orcid.org/0000-0002-5378-0296
Lee, Yeonsoo S.
Tung, Nadine
Hamilton, Jada G.
Gabriel, Camila
Raja, Sahitya C.
Jenkins, Colby
Braswell, Anthony
Domchek, Susan M.
Symecko, Heather
Spielman, Kelsey
Karlan, Beth Y.
Lester, Jenny
Kamara, Daniella
Levin, Jeffrey
Morgan, Kelly
Offit, Kenneth
Garber, Judy
Keating, Nancy L.
-
Funding
Funding for this research was provided by:
American Cancer Society (130741-CCCDA-17-072-01-CCCDA, MRSG-16-020-01-CPPB)
Breast Cancer Research Foundation (BCRF-19-039)
Basser Center for BRCA
National Cancer Institute (P30 CA008748)
Sharon Levine Corzine Foundation
- License Information
-
More Information
Article History
Received: 23 March 2020
Accepted: 22 July 2020
First Online: 17 August 2020
Ethics approval and consent to participate
: Ethics approval was obtained from Advarra (), the independent Institutional Review Board utilized for all study sites, with additional oversight by study institutions. Study participants undergoing <i>BRCA1/2</i> testing provided written informed consent. Consent was implied for providers responding to the surveys.
: Not applicable.
: The authors declare that they have no competing interests.
